I,HAVE RECEIVED THE PRODUCT. I tested it out and my date was tottally satisfied.She
wants to get together now twice a week instead of only once.thank you for a life
changing product.I ALLREADY enjoy my life but to bring joy to her is a great
gift.plus with the dollars we save we can afford to go out.
- satisfied customer stewart
Pernix Therapeutics Introduces Omeclamox-Pak®, First Product in ... - MarketWatch (press release)
Pernix Therapeutics Introduces Omeclamox-Pak®, First Product in .
FDA to Review CV Risk With Azithromycin - Medscape
FDA to Review CV Risk With AzithromycinMedscapeThat class, called macrolides, also includes clarithromycin (Biaxin, Abbott) and erythromycin, neither of which figured into the NEJM study.
Pernix launches new therapy to eradicate H. pylori - Pharmaceutical Business Review
Pernix launches new therapy to eradicate H.
Common antibiotic linked to risk of sudden death, study finds - McKnight's Long Term Care News
Common antibiotic linked to risk of sudden death, study findsMcKnight's Long Term Care NewsAzithromycin, which is frequently referred to as a “Z-Pak,” was generally believed to be safer than antibiotics such as erythromycin and clarithromycin.
Pernix Therapeutics Reports First Quarter 2012 Financial ResultsEON: Enhanced Online News (press release)Omeclamox-Pak® is a ten-day therapy of omeprazole delayed-release capsules (20 mg), clarithromycin tablets (500 mg) and amoxicillin capsules (500 mg) for the treatment of Helicobacter pylori (H.